884512-09-8

Basic information

• Product Name: (R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate
• Synonyms: (R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 3-(3-chlorobenzoyl)-, 1,1-diMethylethyl ester, (3R)-;Tert-butyl (R)-3-(3-chlorobenzoyl)piperidine-1-carboxylate
• CAS NO: 884512-09-8
• Molecular Formula: C₁₇H₂₂ClNO₃
• Molecular Weight: 323.81
• Mol File: 884512-09-8.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 436.2°C at 760 mmHg
• Flash Point: 217.6°C
• Appearance: /
• Density: 1.183g/cm³
• Vapor Pressure: 8.24E-08mmHg at 25°C
• Refractive Index: 1.54
• CAS DataBase Reference: (R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate(884512-09-8)
• EPA Substance Registry System: (R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate(884512-09-8)

Safety Data

• Hazardous Substances Data: 884512-09-8(Hazardous Substances Data)

Usage

General Description

(R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate is a synthetic compound that is commonly used in the pharmaceutical industry. It is a tert-butyl ester derivative of 3-(3-chlorobenzoyl)piperidine-1-carboxylic acid, which is a known intermediate in the synthesis of various pharmaceuticals and building blocks for drug discovery. (R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate has potential biological activity, particularly in the modulation of central nervous system receptors. It is also used as a precursor in the synthesis of various pharmacologically active compounds and may have application in medicinal chemistry research. Its specific properties and potential uses make it an important chemical in the field of drug development and research.

InChI:InChI=1/C17H22ClNO3/c1-17(2,3)22-16(21)19-9-5-7-13(11-19)15(20)12-6-4-8-14(18)10-12/h4,6,8,10,13H,5,7,9,11H2,1-3H3/t13-/m1/s1

Upstream product

• 163438-09-3 (R)-1-Boc-nipecotic acid 
• 108-37-2 1-bromo-3-chlorobenzene 
• 884510-86-5 (R)-tert-butyl 3-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate 
• 25077-87-6 3-chlorophenyllithium 

Downstream Products

• 942142-70-3 (3R)-tert-butyl 3-((3-chlorophenyl)(hydroxy)methyl)piperidine-1-carboxylate 
• 942142-74-7 (R)-tert-butyl 3-((R)-(3-chlorophenyl)(hydroxy)methyl)piperidine-1-carboxylate 
• 884512-54-3 (R)-tert-butyl 3-((S)-1-(3-chlorophenyl)-1-hydroxy-5-methoxypentyl)piperidine-1-carboxylate 
• 942142-76-9 (R)-tert-butyl 3-((R)-(3-chlorophenyl)(2-ethoxy-2-oxoethoxy)methyl)piperidine-1-carboxylate 
• 942145-03-1 (R)-tert-butyl 3-((R)-(3-chlorophenyl)(2-hydroxyethoxy)methyl)piperidine-1-carboxylate 
• 942145-04-2 (R)-tert-butyl 3-((R)-(3-chlorophenyl)(2-(methylsulfonyloxy)ethoxy)methyl)piperidine-1-carboxylate 
• 942145-05-3 (R)-tert-butyl 3-((R)-(2-azidoethoxy)(3-chlorophenyl)methyl)piperidine-1-carboxylate 
• 942142-78-1 (R)-tert-butyl 3-((R)-(2-aminoethoxy)(3-chlorophenyl)methyl)piperidine-1-carboxylate 
• 942142-79-2 (R)-tert-butyl 3-((R)-(3-chlorophenyl)(2-(methoxycarbonylamino)ethoxy)methyl)piperidine-1-carboxylate 
• 942145-39-3 methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-1-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate trifluoroacetate 
• 1013631-24-7 methyl (2-((R)-(3-chlorophenyl)((R)-1-(((S)-1-(methylamino)-3-((S)-tetrahydro-2H-pyran-3-yl)propan-2-yl)carbamoyl)piperidin-3-yl)methoxy)ethyl)carbamate trifluoroacetate 
• 1013937-63-7 methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate trifluoroacetate 
• 942142-81-6 methyl 2-((R)-(3-chlorophenyl)((R)-piperidin-3-yl)methoxy)ethylcarbamate trifluoroacetate 

Relevant articles and documents

Discovery of VTP-27999, an alkyl amine renin inhibitor with potential for clinical utility

Structure guided optimization of a series of nonpeptidic alkyl amine renin inhibitors allowed the rational incorporation of additional polar functionality. Replacement of the cyclohexylmethyl group occupying the S1 pocket with a (R)-(tetrahydropyran-3-yl)

Design and optimization of renin inhibitors: Orally bioavailable alkyl amines

Structure-based drug design led to the identification of a novel class of potent, low MW alkylamine renin inhibitors. Oral administration of lead compound 21l, with MW of 508 and IC50 of 0.47 nM, caused a sustained reduction in mean arterial bl

DIAMINOPROPANOL RENIN INHIBITORS

Described are diaminopropanols of which are orally active and bind to renin to inhibit its activity. They are useful in the treatment or amelioration of diseases associated with elevated levels of renin activity or in the treatment of aspartic protease me